Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
116.93
+2.91 (2.55%)
Oct 2, 2026, 10:03 AM EDT - Market open
Corcept Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 830.81 | 761.41 | 675.04 | 482.38 | 401.86 | 365.98 | |
Revenue Growth | 16.02% | 12.79% | 39.94% | 20.04% | 9.80% | 3.42% |
Cost of Revenue | 14.09 | 12.98 | 10.88 | 6.48 | 5.39 | 5.28 |
Gross Profit | 816.73 | 748.43 | 664.16 | 475.89 | 396.47 | 360.7 |
Selling, General & Admin | 556.47 | 448.73 | 280.32 | 184.26 | 152.85 | 122.36 |
Research & Development | 253.86 | 254.91 | 246.89 | 184.35 | 130.99 | 113.86 |
Operating Expenses | 810.32 | 703.63 | 527.21 | 368.61 | 283.84 | 236.22 |
Operating Income | 6.41 | 44.8 | 136.95 | 107.28 | 112.63 | 124.48 |
Interest & Investment Income | 19.96 | 21.67 | 24.54 | 17.28 | 3.56 | 0.53 |
Legal Settlements | - | - | - | - | -14 | - |
Pretax Income | 26.37 | 66.46 | 161.49 | 124.56 | 116.19 | 125.01 |
Income Tax Expense | -28.81 | -33.19 | 20.28 | 18.42 | 14.77 | 12.49 |
Net Income | 55.18 | 99.65 | 141.21 | 106.14 | 101.42 | 112.51 |
Preferred Dividends & Other Adjustments | 0.91 | 1.48 | 1.48 | 0.64 | 0.13 | - |
Net Income to Common | 54.27 | 98.17 | 139.73 | 105.5 | 101.29 | 112.51 |
Net Income Growth | -58.89% | -29.74% | 32.45% | 4.15% | -9.98% | 6.13% |
Shares Outstanding (Basic) | 104 | 104 | 103 | 104 | 107 | 116 |
Shares Outstanding (Diluted) | 118 | 120 | 113 | 112 | 116 | 126 |
Shares Change | -0.22% | 5.73% | 1.55% | -3.64% | -7.94% | 1.42% |
EPS (Basic) | 0.52 | 0.95 | 1.35 | 1.02 | 0.95 | 0.97 |
EPS (Diluted) | 0.45 | 0.82 | 1.23 | 0.94 | 0.87 | 0.89 |
EPS Growth | -59.30% | -33.33% | 30.85% | 8.05% | -2.25% | 4.71% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 106.92 | 141.79 | 196.12 | 126.54 | 119.91 | 167.42 |
Free Cash Flow Per Share | 0.91 | 1.18 | 1.73 | 1.13 | 1.03 | 1.33 |
Gross Margin | 98.30% | 98.30% | 98.39% | 98.66% | 98.66% | 98.56% |
Operating Margin | 0.77% | 5.88% | 20.29% | 22.24% | 28.03% | 34.01% |
Profit Margin | 6.53% | 12.89% | 20.70% | 21.87% | 25.20% | 30.74% |
Free Cash Flow Margin | 12.87% | 18.62% | 29.05% | 26.23% | 29.84% | 45.75% |
EBITDA | 8.08 | 45.95 | 137.75 | 108.32 | 113.89 | 125.96 |
EBITDA Margin | 0.97% | 6.03% | 20.41% | 22.46% | 28.34% | 34.42% |
D&A For EBITDA | 1.68 | 1.15 | 0.8 | 1.04 | 1.26 | 1.48 |
EBIT | 6.41 | 44.8 | 136.95 | 107.28 | 112.63 | 124.48 |
EBIT Margin | 0.77% | 5.88% | 20.29% | 22.24% | 28.03% | 34.01% |
Effective Tax Rate | - | - | 12.56% | 14.79% | 12.71% | 9.99% |